XML 57 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (Benefit)
Income tax (benefit) expense consists of the following:
 
Year Ended December 31,
 
2018
 
2017
 
2016
Current:
 
 
 
 
 
  Federal
$
6,146

 
$
(1,250
)
 
$
3,813

  State and Local
477

 
360

 
252

    Total Current Income Tax Expense (Benefit)
6,623

 
(890
)
 
4,065

Deferred:
 
 
 
 
 
  Federal
(68,907
)
 
148,997

 
33,999

  State and Local
(11,147
)
 
19,521

 
847

    Total Deferred Income Tax Expense (Benefit)
(80,054
)
 
168,518

 
34,846

Total Income Tax (Benefit) Expense
$
(73,431
)
 
$
167,628

 
$
38,911

Schedule of Reported Provision for Income Taxes and the U.S. Federal Statutory Rate
The difference between New Residential’s reported provision for income taxes and the U.S. federal statutory rate of 21% is as follows:
 
December 31,
 
2018
 
2017
 
2016
Provision at the statutory rate
21.00
 %
 
35.00
 %
 
35.00
 %
Non-taxable REIT income
(25.44
)%
 
(21.72
)%
 
(28.22
)%
State and local taxes
(1.19
)%
 
1.76
 %
 
0.18
 %
Change in valuation allowance
(2.31
)%
 
0.85
 %
 
0.67
 %
Change in federal tax rate
 %
 
(0.92
)%
 
 %
Other
(0.30
)%
 
(0.17
)%
 
(0.48
)%
Total provision
(8.24
)%
 
14.80
 %
 
7.15
 %
Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liability are presented below:
 
December 31,
 
2018
 
2017
Deferred tax assets:
 
 
 
Net operating losses and tax credit carryforwards(B)
$
41,713

 
$
20,682

Interest accruals not currently deductible for tax purposes

 
2,628

Basis differences for REO and other assets
8,453

 
8,034

Unrealized mark to market
36,758

 

Other
3,087

 
2,279

Total deferred tax assets
90,011

 
33,623

Less valuation allowance

 
(12,404
)
Net deferred tax assets
$
90,011

 
$
21,219

 
 
 
 
Deferred tax liabilities:
 
 
 
Basis difference for partnership and other investments
$
(24,179
)
 
$
(3,873
)
Interest accruals not currently includible in income for tax purposes

 
(6,979
)
Unrealized mark to market

 
(29,585
)
Total deferred tax (liability)
$
(24,179
)
 
$
(40,437
)
 
 
 
 
Net deferred tax assets (liability)
$
65,832

 
$
(19,218
)

(A)
As of December 31, 2018, New Residential’s TRSs had approximately $131.3 million of net operating loss carryforwards for federal and state income tax purposes which may be available to offset future taxable income, if and when it arises. Approximately, $131.3 million of these federal and state net operating loss carryforwards will begin to expire in 2034. The utilization of the net operating loss carryforwards to reduce future income taxes will depend on the TRSs ability to generate sufficient taxable income prior to the expiration of the carryforward period.

Summary of Changes in Deferred Tax Asset Valuation Allowance
The following table summarizes the change in the deferred tax asset valuation allowance:
Valuation allowance at December 31, 2016
 
$
10,054

Increase related to net operating losses and loan loss reserves
 
4,720

Decrease related to changes in tax rates
 
(3,845
)
Other increase (decrease)
 
1,475

Valuation allowance at December 31, 2017
 
12,404

Increase related to net operating losses and loan loss reserves
 
18,769

Decrease related to changes in tax rates
 

Other increase (decrease)
 
(31,173
)
Valuation allowance at December 31, 2018
 
$

Schedule of Taxable Common Stock Distributions
Common stock distributions were taxable as follows:
Year
Dividends
per Share
 
Ordinary
Income
 
Long-term
Capital
Gain
 
Return
of
Capital
2018(A)
$
1.60

 
78.03
%
 
1.03
%
 
20.94
%
2017(B)
1.94

 
66.64
%
 
7.83
%
 
25.53
%
2016
1.38

 
96.13
%
 
3.87
%
 
%


(A)
The entire $0.50 per share dividend declared in December 2018 and paid in January 2019 is treated as received by stockholders in 2019.
(B)
The entire $0.50 per share dividend declared in December 2017 and paid in January 2018 is treated as received by stockholders in 2018.